Eric Rothe - Net Worth and Insider Trading

Eric Rothe Net Worth

The estimated net worth of Eric Rothe is at least $4 Million dollars as of 2024-11-13. Eric Rothe is the Director of Greenwich LifeSciences Inc and owns about 313,226 shares of Greenwich LifeSciences Inc (GLSI) stock worth over $4 Million. Details can be seen in Eric Rothe's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Eric Rothe has not made any transactions after 2020-11-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Eric Rothe

To

Eric Rothe Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Eric Rothe owns 1 companies in total, including Greenwich LifeSciences Inc (GLSI) .

Click here to see the complete history of Eric Rothe’s form 4 insider trades.

Insider Ownership Summary of Eric Rothe

Ticker Comapny Transaction Date Type of Owner
GLSI Greenwich LifeSciences Inc 2020-11-20 director

Eric Rothe Latest Holdings Summary

Eric Rothe currently owns a total of 1 stock. Eric Rothe owns 313,226 shares of Greenwich LifeSciences Inc (GLSI) as of November 20, 2020, with a value of $4 Million.

Latest Holdings of Eric Rothe

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
GLSI Greenwich LifeSciences Inc 2020-11-20 313,226 13.57 4,250,477

Holding Weightings of Eric Rothe


Eric Rothe Form 4 Trading Tracker

According to the SEC Form 4 filings, Eric Rothe has made a total of 1 transactions in Greenwich LifeSciences Inc (GLSI) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Greenwich LifeSciences Inc is the acquisition of 2,000 shares on November 20, 2020, which cost Eric Rothe around $10,800.

Insider Trading History of Eric Rothe

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Eric Rothe Trading Performance

GuruFocus tracks the stock performance after each of Eric Rothe's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Eric Rothe is 576.69%. GuruFocus also compares Eric Rothe's trading performance to market benchmark return within the same time period. The performance of stocks bought by Eric Rothe within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Eric Rothe's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Eric Rothe

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 618.42 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 614.15 LIMIT LIMIT LIMIT LIMIT LIMIT

Eric Rothe Ownership Network

Ownership Network List of Eric Rothe

No Data

Ownership Network Relation of Eric Rothe

Insider Network Chart

Eric Rothe Owned Company Details

What does Greenwich LifeSciences Inc do?

Who are the key executives at Greenwich LifeSciences Inc?

Eric Rothe is the director of Greenwich LifeSciences Inc. Other key executives at Greenwich LifeSciences Inc include director & CHIEF EXECUTIVE OFFICER Snehal Patel , VPC AND REGULATORY AFFAIRS Jaye Thompson , and director & CHIEF MEDICAL OFFICER Frank Joseph Daugherty .

Greenwich LifeSciences Inc (GLSI) Insider Trades Summary

Over the past 18 months, Eric Rothe made no insider transaction in Greenwich LifeSciences Inc (GLSI). Other recent insider transactions involving Greenwich LifeSciences Inc (GLSI) include a net purchase of 280,425 shares made by Snehal Patel , and a net purchase of 4,150 shares made by Jaye Thompson .

In summary, during the past 3 months, insiders sold 0 shares of Greenwich LifeSciences Inc (GLSI) in total and bought 1,500 shares, with a net purchase of 1,500 shares. During the past 18 months, 0 shares of Greenwich LifeSciences Inc (GLSI) were sold and 284,575 shares were bought by its insiders, resulting in a net purchase of 284,575 shares.

Greenwich LifeSciences Inc (GLSI)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Greenwich LifeSciences Inc Insider Transactions

No Available Data

Eric Rothe Mailing Address

Above is the net worth, insider trading, and ownership report for Eric Rothe. You might contact Eric Rothe via mailing address: 2311 Spartan Trail, Sugar Land Tx 77479.